Low risk of developing Borrelia burgdorferi infection in the south-east of Sweden after being bitten by a Borrelia burgdorferi-infected tick

International Journal of Infectious Diseases

Volumn 15, Issue 3, 2011, Pages

  Fryland, Linda ^a   Wilhelmsson, Peter ^a   Lindgren, Per Eric ^a   Nyman, Dag ^b   Ekerfelt, Christina ^a   Forsberg, Pia ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Åland Borrelia Group   (Finland)

Author keywords

Anti Borrelia antibodies; Borrelia burgdorferi sensu lato; Clinical outcome; Lyme borreliosis; Tick bite

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BORRELIA BURGDORFERI; FEMALE; HUMAN; INFECTION RISK; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; QUESTIONNAIRE; SEROCONVERSION; SPIROCHETE; SWEDEN; TICK BITE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; FEMALE; HUMANS; IXODES; LYME DISEASE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEX DISTRIBUTION; SWEDEN; YOUNG ADULT;

EID: 79952107184     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.10.006     Document Type: Article

References (42)

1. Dennis DT, Hayes EB, Epidemiology of Lyme borreliosis. In: Gray J, Kohl O, Lane RS, Stanek G, editors. Lyme borreliosis: biology, epidemiology and control. New York: CABI Publishing; 2002, p. 251-80.
2. Baranton G., Postic D., Saint Girons I., Boerlin P., Piffaretti J.C., Assous M., et al. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 1992, 42:378-383.
3. Richter D., Schlee D.B., Allgower R., Matuschka F.R. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in Central Europe. Appl Environ Microbiol 2004, 70:6414-6419.
4. Hubalek Z. Epidemiology of Lyme borreliosis. Curr Probl Dermatol 2009, 37:31-50.
5. O'Connell S., Granstrom M., Gray J.S., Stanek G. Epidemiology of European Lyme borreliosis. Zentralbl Bakteriol 1998, 287:229-240.
6. Nyman D. Lyme-borrelios-det åländska perspektivet på en fästingburen landsplåga. Finska Läkaresällskapets Handlingar 2002, 162:26-29.
7. Bennet L., Halling A., Berglund J. Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers. Eur J Clin Microbiol Infect Dis 2006, 25:426-432.
8. Berglund J., Eitrem R., Ornstein K., Lindberg A., Ringer A., Elmrud H., et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995, 333:1319-1327.
9. Ekerfelt C., Forsberg P., Svenvik M., Roberg M., Bergstrom S., Ernerudh J. Asymptomatic Borrelia-seropositive individuals display the same incidence of Borrelia-specific interferon-gamma (IFN-gamma)-secreting cells in blood as patients with clinical Borrelia infection. Clin Exp Immunol 1999, 115:498-502.
10. Ekerfelt C., Masreliez C., Svenvik M., Ernerudh J., Roberg M., Forsberg P. Antibodies and T-cell reactivity to Borrelia burgdorferi in an asymptomatic population: a study of healthy blood donors in an inland town district in the south-east of Sweden. Scand J Infect Dis 2001, 33:806-808.
11. Berglund J., Stjernberg L., Ornstein K., Tykesson-Joelsson K., Walter H. 5-y Follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002, 34:421-425.
12. Kaiser R. Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. J Neurol 1994, 242:26-36.
13. Nocton J.J., Steere A.C. Lyme disease. Adv Intern Med 1995, 40:69-117.
14. Oschmann P., Dorndorf W., Hornig C., Schafer C., Wellensiek H.J., Pflughaupt K.W. Stages and syndromes of neuroborreliosis. J Neurol 1998, 245:262-272.
15. Steere A.C. Lyme disease. N Engl J Med 2001, 345:115-125.
16. Jacobs J.J., Noordhoek G.T., Brouwers J.M., Wielinga P.R., Jacobs J.P., Brandenburg A.H. [Small risk of developing Lyme borreliosis following a tick bite on Ameland: research in a general practice]. Ned Tijdschr Geneeskd 2008, 152:2022-2026.
17. Maiwald M., Oehme R., March O., Petney T.N., Kimmig P., Naser K., et al. Transmission risk of Borrelia burgdorferi sensu lato from Ixodes ricinus ticks to humans in southwest Germany. Epidemiol Infect 1998, 121:103-108.
18. Nadelman R.B., Nowakowski J., Fish D., Falco R.C., Freeman K., McKenna D., et al. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med 2001, 345:79-84.
19. Nahimana I., Gern L., Blanc D.S., Praz G., Francioli P., Peter O. Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite. Eur J Clin Microbiol Infect Dis 2004, 23:603-608.
20. Shapiro E.D., Gerber M.A., Holabird N.B., Berg A.T., Feder H.M., Bell G.L., et al. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med 1992, 327:1769-1773.
21. Steere A.C., Sikand V.K., Schoen R.T., Nowakowski J. Asymptomatic infection with Borrelia burgdorferi. Clin Infect Dis 2003, 37:528-532.
22. Wilhelmsson P., Fryland L., Borjesson S., Nordgren J., Bergstrom S., Ernerudh J., et al. Prevalence and diversity of Borrelia species in ticks that have bitten humans in Sweden. J Clin Microbiol 2010, 48:4169-4176.
23. Ornstein K., Barbour A.G. A reverse transcriptase-polymerase chain reaction assay of Borrelia burgdorferi 16S rRNA for highly sensitive quantification of pathogen load in a vector. Vector Borne Zoonotic Dis 2006, 6:103-112.
24. Postic D., Assous M.V., Grimont P.A., Baranton G. Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons. Int J Syst Bacteriol 1994, 44:743-752.
25. Bunikis J., Garpmo U., Tsao J., Berglund J., Fish D., Barbour A.G. Sequence typing reveals extensive strain diversity of the Lyme borreliosis agents Borrelia burgdorferi in North America and Borrelia afzelii in Europe. Microbiology 2004, 150:1741-1755.
26. Pal U., Fikrig E. Adaptation of Borrelia burgdorferi in the vector and vertebrate host. Microbes Infect 2003, 5:659-666.
27. Schwan T.G., Piesman J. Vector interactions and molecular adaptations of Lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg Infect Dis 2002, 8:115-121.
28. Crippa M., Rais O., Gern L. Investigations on the mode and dynamics of transmission and infectivity of Borrelia burgdorferi sensu stricto and Borrelia afzelii in Ixodes ricinus ticks. Vector Borne Zoonotic Dis 2002, 2:3-9.
29. Kahl O., Janetzki-Mittmann C., Gray J.S., Jonas R., Stein J., de Boer R. Risk of infection with Borrelia burgdorferi sensu lato for a host in relation to the duration of nymphal Ixodes ricinus feeding and the method of tick removal. Zentralbl Bakteriol 1998, 287:41-52.
30. Aguero-Rosenfeld M.E., Wang G., Schwartz I., Wormser G.P. Diagnosis of Lyme borreliosis. Clin Microbiol Rev 2005, 18:484-509.
31. Ekerfelt C., Ernerudh J., Forsberg P., Jonsson A.L., Vrethem M., Arlehag L., et al. Lyme borreliosis in Sweden-diagnostic performance of five commercial Borrelia serology kits using sera from well-defined patient groups. APMIS 2004, 112:74-78.
32. Goossens H.A., van den Bogaard A.E., Nohlmans M.K. Evaluation of fifteen commercially available serological tests for diagnosis of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 1999, 18:551-560.
33. Ledue T.B., Collins M.F., Young J., Schriefer M.E. Evaluation of the recombinant VlsE-based liaison chemiluminescence immunoassay for detection of Borrelia burgdorferi and diagnosis of Lyme disease. Clin Vaccine Immunol 2008, 15:1796-1804.
34. Nohlmans M.K., Blaauw A.A., van den Bogaard A.E., van Boven C.P. Evaluation of nine serological tests for diagnosis of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 1994, 13:394-400.
35. Philipp M.T., Bowers L.C., Fawcett P.T., Jacobs M.B., Liang F.T., Marques A.R., et al. Antibody response to IR6, a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and in humans. J Infect Dis 2001, 184:870-878.
36. Tjernberg I., Kruger G., Eliasson I. C6 peptide ELISA test in the serodiagnosis of Lyme borreliosis in Sweden. Eur J Clin Microbiol Infect Dis 2007, 26:37-42.
37. Fleming R.V., Marques A.R., Klempner M.S., Schmid C.H., Dally L.G., Martin D.S., et al. Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 2004, 23:615-618.
38. Cerar D., Cerar T., Ruzic-Sabljic E., Wormser G.P., Strle F. Subjective symptoms after treatment of early Lyme disease. Am J Med 2010, 123:79-86.
39. Ginaldi L., De Martinis M., D'Ostilio A., Marini L., Loreto M.F., Quaglino D. The immune system in the elderly: III. Innate immunity. Immunol Res 1999, 20:117-126.
40. Gomez C.R., Nomellini V., Faunce D.E., Kovacs E.J. Innate immunity and aging. Exp Gerontol 2008, 43:718-728.
41. Listi F., Candore G., Modica M.A., Russo M., Di Lorenzo G., Esposito-Pellitteri M., et al. A study of serum immunoglobulin levels in elderly persons that provides new insights into B cell immunosenescence. Ann N Y Acad Sci 2006, 1089:487-495.
42. Paganelli R., Quinti I., Fagiolo U., Cossarizza A., Ortolani C., Guerra E., et al. Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population. Clin Exp Immunol 1992, 90:351-354.